Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EHSIElite Health Systems Inc.

OTC · CIK 0001089815
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC8093 Services-Specialty Outpatient Facilities, NEC
FY end1231
XBRL facts351

Identity from submissions API

NameElite Health Systems Inc.
CIK0001089815
TickersEHSI
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC8093 Services-Specialty Outpatient Facilities, NEC
EIN521842411
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone949-249-1170
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Elite Health Systems, Inc. (2024-10-03T00:00:00.000Z → 2024-10-03T00:00:00.000Z)
  • U.S. NeuroSurgical Holdings, Inc. (2015-09-03T00:00:00.000Z → 2024-08-09T00:00:00.000Z)
  • US NEUROSURGICAL INC (1999-08-10T00:00:00.000Z → 2015-08-14T00:00:00.000Z)
Business address
1131 W 6TH STREET
SUITE 225
ONTARIO
CA
91762
CA
Mailing address
1131 W 6TH STREET
SUITE 225
ONTARIO
CA
91762
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

230 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 10-Q FORM 10-Q 0001437749-26-037860 000-26575 261578419 34 3743506 1 1
2026-11-20 8-K FORM 8-K 3.02 0001437749-26-037852 000-26575 261578257 34 142247 1 1
2026-11-16 NT 10-Q FORM NT 10-Q 0001437749-26-037042 000-26575 261556623 34 38544
2026-09-09 4 FORM 4 0001437749-26-029947 7008
2026-08-19 10-Q FORM 10-Q 0001437749-26-028491 000-26575 261294077 34 3538122 1 1
2026-08-14 NT 10-Q FORM NT 10-Q 0001437749-26-027880 000-26575 261278201 34 37433
2026-08-05 8-K FORM 8-K 1.01,9.01 0001437749-26-025897 000-26575 261242811 34 179228 1 1
2026-08-04 4 FORM 4 0001437749-26-025736 7018
2026-07-10 8-K FORM 8-K 8.01 0001437749-26-023293 000-26575 261168213 34 147080 1 1
2026-07-09 4 FORM 4 0001437749-26-023178 5766
2026-06-09 4 PRIMARY DOCUMENT 0001999391-26-000002 6616
2026-05-20 10-Q FORM 10-Q 0001437749-26-017934 000-26575 261003748 34 3295619 1 1
2026-05-15 NT 10-Q FORM NT 10-Q 0001437749-26-017363 000-26575 26986520 34 25353
2026-05-13 4 PRIMARY DOCUMENT 0001999391-26-000001 5139
2026-04-15 10-K FORM 10-K 0001437749-26-012312 000-26575 26862821 34 5378878 1 1
2026-04-01 NT 10-K FORM NT 10-K 0001437749-26-010876 000-26575 26827995 34 28905
2026-01-08 4 FORM 4 0001437749-26-000881 7041
2025-12-29 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001437749-25-038869 005-56875 251610400 34 10966
2025-12-03 4 FORM 4 0001437749-25-036733 5519
2025-11-13 10-Q FORM 10-Q 0001437749-25-034794 000-26575 251477860 34 3573521 1 1
2025-11-05 8-K FORM 8-K 5.07 0001437749-25-033163 000-26575 251452118 34 168617 1 1
2025-09-29 DEF 14A FORM DEF 14A 0001437749-25-030001 000-26575 251355114 34 1650934 1 1
2025-09-29 8-K FORM 8-K 1.01 0001437749-25-029995 000-26575 251355043 34 137487 1 1
2025-09-23 UPLOAD filename1.pdf 0000000000-25-010364 000-26575 40133
2025-09-18 CORRESP filename1.htm 0001437749-25-029390 237788
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010005 000-26575 42649
2025-09-02 PRE 14A FORM PRE 14A 0001437749-25-028137 000-26575 251285009 34 1876194 1 1
2025-09-02 8-K FORM 8-K 1.01 0001437749-25-028131 000-26575 251284880 34 136729 1 1
2025-08-13 10-Q FORM 10-Q 0001437749-25-026553 000-26575 251212454 34 3330678 1 1
2025-08-08 4 FORM 4 0001437749-25-025760 5185
2025-08-08 4 FORM 4 0001437749-25-025759 5273
2025-08-08 4 FORM 4 0001437749-25-025757 7701
2025-08-08 4 FORM 4 0001437749-25-025754 6598
2025-08-08 4 FORM 4 0001437749-25-025752 6701
2025-07-31 8-K FORM 8-K 5.02 0001437749-25-024116 000-26575 251170702 34 139706 1 1
2025-07-31 3 FORM 3 0001437749-25-024115 3636
2025-07-31 D xslFormDX01/primary_doc.xml 06b 0001437749-25-024114 021-553352 251170698 33 9664
2025-07-03 8-K FORM 8-K 3.02,8.01 0001437749-25-022124 000-26575 251105207 34 146055 1 1
2025-06-09 8-K FORM 8-K 1.01 0001437749-25-019877 000-26575 251034798 34 135204 1 1
2025-06-05 8-K FORM 8-K 1.01 0001437749-25-019545 000-26575 251027074 34 138669 1 1
2025-05-30 8-K FORM 8-K 1.01 0001437749-25-018958 000-26575 251010599 34 140487 1 1
2025-05-15 10-Q FORM 10-Q 0001437749-25-017141 000-26575 25951543 34 3045658 1 1
2025-05-02 4 FORM 4 0001437749-25-014311 5464
2025-04-02 10-K FORM 10-K 0001437749-25-010652 000-26575 25804176 34 5378811 1 1
2025-03-31 NT 10-K FORM NT 10-K 0001437749-25-010240 000-26575 25794364 34 50732
2025-02-26 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-003498 005-56875 25669523 34 10258
2024-12-05 D/A xslFormDX01/primary_doc.xml 06b 0001361943-24-000005 021-502078 241529574 33 9147
2024-12-02 8-K FORM 8-K 1.01,8.01 0001437749-24-036471 000-26575 241519630 34 140236 1 1
2024-12-02 4 FORM 4 0001437749-24-036470 5711
2024-12-02 4 FORM 4 0001437749-24-036469 4742
2024-12-02 4 FORM 4 0001437749-24-036468 4842
2024-11-13 10-Q FORM 10-Q 0001437749-24-034956 000-26575 241455437 34 3631520 1 1
2024-11-06 4 FORM 4 0001437749-24-033534 6831
2024-10-03 8-K FORM 8-K 5.03,8.01,9.01 0001437749-24-030640 000-26575 241352640 34 159976 1 1
2024-08-09 10-Q FORM 10-Q 0001437749-24-025847 000-26575 241192427 34 3640884 1 1
2024-07-18 D/A xslFormDX01/primary_doc.xml 06b 0001361943-24-000003 021-502078 241125563 33 8780
2024-07-12 8-K FORM 8-K 1.01,5.02 0001437749-24-022636 000-26575 241114143 34 142854 1 1
2024-05-15 10-Q 10-Q 0001140361-24-026235 000-26575 24950496 34 4203947 1 1
2024-04-24 10-K/A 10-K/A 0001140361-24-021725 000-26575 24870806 34 263876 1 1
2024-04-05 10-K 10-K 0001140361-24-018303 000-26575 24826408 34 5706475 1 1
2024-04-01 NT 10-K NT 10-K 0001140361-24-016901 000-26575 24809131 34 15713
2024-03-06 D/A xslFormDX01/primary_doc.xml 06b 0001361943-24-000002 021-502078 24726460 33 9784
2024-01-18 8-K 8-K 1.01,9.01 0001140361-24-002644 000-26575 24540260 34 229198 1 1
2024-01-10 D xslFormDX01/primary_doc.xml 06b 0001361943-24-000001 021-502078 24526310 33 9646
2023-12-05 3 PRIMARY DOCUMENT 0001999391-23-000001 4330
2023-12-05 SC 13D SC 13D 0001140361-23-056352 005-56875 231466537 34 71182
2023-11-28 8-K FORM 8-K 1.01,8.01,9.01 0001140361-23-054994 000-26575 231446297 34 204412 1 1
2023-11-14 10-Q 10-Q 0001140361-23-053308 000-26575 231408071 34 4454994 1 1
2023-08-14 10-Q 10-Q 0001140361-23-039358 000-26575 231165963 34 4492410 1 1
2023-05-15 10-Q 10-Q 0001140361-23-024507 000-26575 23918698 34 3894888 1 1
2023-04-20 3 PRIMARY DOCUMENT 0001701515-23-000002 3929
2023-04-19 8-K 8-K 5.02 0001140361-23-019127 000-26575 23830033 34 148610 1 1
2023-04-13 10-K 10-K 0001140361-23-018265 000-26575 23819119 34 6247749 1 1
2023-04-03 NT 10-K NT 10-K 0001140361-23-015644 000-26575 23790730 34 15581
2022-11-21 10-Q 10-Q 0001140361-22-042557 000-26575 221406629 34 5226748 1 1
2022-11-14 NT 10-Q NONE 0001567619-22-019636 000-26575 221379488 34 13133
2022-09-26 4 PRIMARY DOCUMENT 0001361943-22-000001 4709
2022-09-13 8-K 8-K 4.01,9.01 0001140361-22-033207 000-26575 221241553 34 199321 1 1
2022-08-12 10-Q 10-Q 0001140361-22-029417 000-26575 221159862 34 5204251 1 1
2022-08-11 10-Q/A 10-Q/A 0001140361-22-029264 000-26575 221156287 34 4758769 1 1
2022-08-04 8-K 8-K 4.02 0001140361-22-028102 000-26575 221134339 34 149540 1 1
2022-06-24 10-Q 10-Q 0001140361-22-023991 000-26575 221040160 34 4749079 1 1
2022-06-24 10-K/A 10-K/A 0001140361-22-023989 000-26575 221040109 34 9574135 1 1
2022-06-02 8-K 8-K 4.02 0001140361-22-021510 000-26575 22988542 34 149046 1 1
2022-05-16 NT 10-Q NONE 0001567619-22-010922 000-26575 22928385 34 13063
2022-04-15 10-K 10-K 0001140361-22-014709 000-26575 22829568 34 7170715 1 1
2022-03-31 NT 10-K NONE 0001567619-22-007761 000-26575 22792290 34 13169
2021-11-19 10-Q 10-Q 0001140361-21-038700 000-26575 211428287 34 5810903 1 1
2021-11-15 NT 10-Q NT 10-Q 0001140361-21-037887 000-26575 211410953 34 15614
2021-10-06 8-K 8-K 1.01,9.01 0001140361-21-033882 000-26575 211309798 34 380129 1 1
2021-08-11 10-Q 10-Q 0001140361-21-027937 000-26575 211163681 34 5719384 1 1
2021-05-17 10-Q 10-Q 0001140361-21-017645 000-26575 21930210 34 3570114 1
2021-04-07 10-K 10-K 0001140361-21-011976 000-26575 21812070 34 6120987 1
2021-03-31 NT 10-K NONE 0001567619-21-007288 000-26575 21793128 34 13132
2020-11-13 10-Q 10-Q 0001140361-20-025513 000-26575 201312110 34 4235073 1
2020-08-14 10-Q 10-Q 0001140361-20-018474 000-26575 201104912 34 4160494 1
2020-05-15 10-Q 10-Q 0001140361-20-011787 000-26575 20886771 34 3572409 1
2020-04-13 10-K 10-K 0001140361-20-008735 000-26575 20789141 34 6195130 1
2020-03-30 NT 10-K NONE 0001567619-20-007147 000-26575 20754583 34 13127
2019-11-14 10-Q 10-Q 0001140361-19-020592 000-26575 191220418 34 4061588 1
2019-08-14 10-Q 10-Q 0001140361-19-015062 000-26575 191027627 34 3856799 1
2019-05-14 10-Q 10-Q 0001140361-19-009121 000-26575 19823701 34 3716991 1
2019-04-11 10-K 10-K 0001140361-19-006932 000-26575 19743812 34 6191864 1
2019-04-01 NT 10-K NONE 0001567619-19-007913 000-26575 19719744 34 13116
2018-11-14 10-Q 10-Q 0001140361-18-043097 000-26575 181184076 34 3848044 1
2018-08-14 10-Q 10-Q 0001140361-18-036346 000-26575 181017264 34 3685478 1
2018-05-15 10-Q 10-Q 0001140361-18-023881 000-26575 18836186 34 3108577 1
2018-04-11 10-K 10-K 0001140361-18-018180 000-26575 18750295 34 5201107 1
2018-03-30 NT 10-K NONE 0001140361-18-016188 000-26575 18725902 34 13117
2017-11-17 10-Q 10-Q 0001140361-17-043211 000-26575 171211084 34 2972168 1
2017-11-14 NT 10-Q NONE 0001140361-17-042721 000-26575 171201372 34 13127
2017-08-14 10-Q 10-Q 0001140361-17-031944 000-26575 171030009 34 2871683 1
2017-05-15 10-Q 10-Q 0001140361-17-020222 000-26575 17841348 34 2593525 1
2017-03-31 10-K U.S. NEUROSURGICAL HOLDINGS, INC. 10-K 12-31-2016 0001140361-17-014197 000-26575 17730283 34 4345086 1
2016-11-14 10-Q U.S. NEUROSURGICAL HOLDINGS, INC. 10-Q 9-30-2016 0001140361-16-086382 000-26575 161994665 34 2620881 1
2016-08-12 10-Q U.S. NEUROSURGICAL HOLDINGS, INC. 10-Q 6-30-2016 0001140361-16-076172 000-26575 161828199 34 2502224 1
2016-05-12 10-Q U.S. NEUROSURGICAL HOLDINGS, INC. 10-Q 3-31-2016 0001140361-16-064750 000-26575 161642786 34 2209599 1
2016-03-30 10-K U.S. NEUROSURGICAL HOLDINGS, INC. 10-K 12-31-2015 0001140361-16-059518 000-26575 161539934 34 3873350 1
2015-11-16 10-Q U.S. NEUROSURGICAL HOLDINGS, INC 10-Q 9-30-2015 0001140361-15-041345 000-26575 151232257 34 2553409 1
2015-09-03 8-K12G3 U.S. NEUROSURGICAL HOLDINGS, INC. 8-K12G3 9-3-2015 1.01,5.03,9.01 0001140361-15-034349 000-26575 151091960 34 138338
2015-08-14 10-Q U.S. NEUROSURGICAL, INC. 10-Q 6-30-2015 0001140361-15-032164 000-26575 151055313 34 2487601 1
2015-05-15 10-Q U.S. NEUROSURGICAL, INC. 10-Q 3-31-2015 0001140361-15-020107 000-26575 15867564 34 2868984 1
2015-03-31 8-K U.S. NEUROSURGICAL, INC 8-K 3-27-2015 4.02 0001140361-15-013677 000-26575 15738517 34 28935
2015-03-31 10-K US NEUROSURGICAL INC 10-K 12-31-2014 0001140361-15-013673 000-26575 15738509 34 6078056 1
2014-11-13 10-Q US NEUROSURGICAL INC 10-Q 9-30-2014 0001140361-14-041417 000-26575 141216515 34 3819396 1
2014-08-14 10-Q US NEUROSURGICAL INC 10-Q 6-30-2014 0001140361-14-032359 000-26575 141039274 34 3814606 1
2014-05-15 10-Q US NEUROSURGICAL INC 10-Q 3-31-2014 0001140361-14-021089 000-26575 14843594 34 3396793 1
2014-04-14 10-K U.S. NEUROSURGICAL, INC 10-K 12-31-2013 0001140361-14-016669 000-26575 14763217 34 4923636 1
2014-03-28 NT 10-K NONE 0001140361-14-014492 000-26575 14723168 34 14088
2014-02-07 8-K U.S. NEUROSURGICAL, INC. 8-K 2-7-2014 4.01 0001140361-14-005250 000-26575 14582948 34 19465
2013-12-16 8-K U.S. NEUROSURGICAL, INC. 8-K 12-16-2013 4.01 0001140361-13-046328 000-26575 131279611 34 26423
2013-11-14 10-Q US NEUROSURGICAL, INC 10-Q 9-30-2013 0001140361-13-042500 000-26575 131217937 34 3045309 1
2013-08-13 10-Q U.S. NEUROSURGICAL, INC 10-Q 6-30-2013 0001140361-13-032016 000-26575 131032909 34 4304395 1
2013-05-14 10-Q U.S. NEUROSURGICAL INC 10-Q 3-31-2013 0001140361-13-020454 000-26575 13838849 34 2717477 1
2013-04-01 10-K US NEUROSURGICAL, INC 10-K 12-31-2012 0001140361-13-014649 000-26575 13728824 34 6293296 1
2012-11-13 10-Q US NEUROSURGICAL INC 10-Q 9-30-2012 0001140361-12-046592 000-26575 121195475 34 2710259 1
2012-08-14 10-Q US NEUROSURGICAL INC 10-Q 6-30-2012 0001140361-12-036761 000-26575 121030234 34 2630023 1
2012-05-15 10-Q U.S. NEUROSURGICAL INC 10-Q 3-31-2012 0001140361-12-025558 000-26575 12846462 34 1348310 1
2012-03-30 10-K U.S.NEUROSURGICAL INC 10-K 12-31-2011 0001140361-12-018385 000-26575 12730362 34 3242908 1
2012-02-13 5 PRIMARY DOCUMENT 0001361943-12-000004 3474
2012-02-13 5 PRIMARY DOCUMENT 0001361943-12-000003 3890
2012-02-13 5 PRIMARY DOCUMENT 0001361943-12-000002 3598
2011-11-21 10-Q US NEUROSURGICAL INC 10-Q 9-30-2011 0001140361-11-054460 000-26575 111218346 34 1652822 1
2011-11-18 UPLOAD filename1.pdf 0000000000-11-067175 45278
2011-11-15 NT 10-Q NONE 0001140361-11-053580 000-26575 111205310 34 12976
2011-11-08 CORRESP filename1.htm 0001140361-11-052140 15058
2011-11-08 10-Q/A US NEUROSURGICAL 10-Q A 6-30-2011 0001140361-11-052138 000-26575 111186155 34 46196
2011-11-08 10-Q/A US NEUROSURGICAL 10-Q A 3-31-2011 0001140361-11-052136 000-26575 111186145 34 49649
2011-11-08 10-K/A US NEUROSURGICAL 10-K A 12-31-2010 0001140361-11-052130 000-26575 111186016 34 649276
2011-10-26 UPLOAD filename1.pdf 0000000000-11-062629 55850
2011-08-15 10-Q US NEUROSURGICAL INC 10-Q 6-30-2011 0001140361-11-041816 000-26575 111034736 34 1211091 1
2011-06-02 SC 13D SCHEDULE 13D 0001204459-11-001582 005-56875 11886355 34 144777
2011-06-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-11-002450 4369
2011-06-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-11-002448 5491
2011-05-16 10-Q US NERUROSURICAL INC 10-Q 3-31-2011 0001140361-11-027957 000-26575 11848606 34 288877
2011-04-08 8-K U.S. NEUROSURGICAL, INC 8-K 4-4-2011 4.01 0001140361-11-021390 000-26575 11747970 34 26730
2011-03-31 10-K US NEUROSURGICAL 10-K 12-31-2010 0001140361-11-019693 000-26575 11726432 34 903848
2010-11-15 10-Q US NEUROSURGICAL, INC 10-Q 9-30-2010 0001140361-10-045422 000-26575 101189099 34 296689
2010-08-16 10-Q U.S. NEUROSURGICAL, INC 10-Q 6-30-2010 0001140361-10-033811 000-26575 101021026 34 281962
2010-05-17 10-Q US NEROSURGICAL 10-Q 3-31-2010 0001140361-10-021605 000-26575 10837665 34 238977
2010-03-30 10-K U.S. NEUROSURGICAL 10-K 12-31-2009 0001140361-10-014176 000-26575 10714417 34 813980
2009-11-16 10-Q US NEUROSURGICAL 10-Q 9-30-2009 0001140361-09-026137 000-26575 091184168 34 316083
2009-08-14 10-Q U.S NEUROSURGICAL, INC. 10-Q 6-30-2009 0001140361-09-019033 000-26575 091015796 34 333653
2009-05-15 10-Q QUARTERLY REPORT 0001169232-09-002620 000-26575 09830792 34 219449
2009-03-31 10-K ANNUAL REPORT 0001169232-09-001774 000-26575 09716764 34 506481
2008-11-13 10-Q QUARTERLY REPORT 0001169232-08-004165 000-26575 081184533 34 198704
2008-08-13 10-Q QUARTERLY REPORT 0001169232-08-003007 000-26575 081011460 34 185522
2008-05-14 10QSB QUARTERLY REPORT 0001169232-08-002048 000-26575 08829262 34 161751
2008-03-31 10KSB ANNUAL REPORT 0001169232-08-001494 000-26575 08721467 34 573927
2008-02-11 SC 13G/A SCHEDULE 13G AMENDMENT NO. 4 0000932799-08-000043 005-56875 08593343 34 11118
2007-11-14 10QSB QUARTERLY REPORT 0001169232-07-004272 000-26575 071241473 34 130895
2007-08-14 10QSB QUARTERLY REPORT 0001169232-07-003283 000-26575 071051262 34 140993
2007-05-15 10QSB QUARTERLY REPORT (SMALL BUSINESS) 0001169232-07-002342 000-26575 07849485 34 107626
2007-04-02 10KSB ANNUAL REPORT 0001169232-07-001720 000-26575 07735674 34 577556
2006-11-14 10QSB QUARTERLY REPORT 0001169232-06-004499 000-26575 061216056 34 180487
2006-08-14 10QSB QUARTERLY REPORT 0001169232-06-003444 000-26575 061026855 34 144320
2006-05-15 10QSB QUARTERLY REPORT 0001169232-06-002406 000-26575 06837113 34 157420
2006-04-03 UPLOAD filename1.pdf 0000000000-06-015724 19662
2006-03-30 10-K ANNUAL REPORT 0001169232-06-001743 000-26575 06721661 34 657313
2006-03-10 10-Q/A QUARTERLY REPORT 0001169232-06-001463 000-26575 06677589 34 159342
2006-03-09 10-K/A AMENDMENT NO. 1 TO ANNUAL REPORT 0001169232-06-001447 000-26575 06675522 34 551259
2006-03-01 CORRESP filename1.htm 0001169232-06-001324 17400
2006-02-17 CORRESP filename1.htm 0001169232-06-000975 25912
2006-02-07 UPLOAD filename1.pdf 0000000000-06-006588 48898
2006-02-01 CORRESP filename1.htm 0001169232-06-000340 404607
2006-01-03 CORRESP filename1.htm 0001169232-06-000011 7643
2005-11-14 10QSB QUARTERLY REPORT 0001169232-05-005321 000-26575 051195981 34 145968
2005-09-19 CORRESP filename1.htm 0001169232-05-004611 6574
2005-08-09 10-Q QUARTERLY REPORT 0001169232-05-003970 000-26575 051008606 34 139281
2005-05-13 10-Q QUARTERLY REPORT 0001169232-05-002652 000-26575 05826784 34 133438
2005-04-13 10-K ANNUAL REPORT 0001169232-05-002089 000-26575 05747633 34 401269
2005-03-28 NT 10-K NOTIFICATION OF LATE FILING OF 10-K 0001169232-05-001832 000-26575 05706273 34 8822
2004-12-23 8-K/A AMENDMENT TO 8-K 4.01,9.01 0001169232-04-006158 000-26575 041222497 34 8254
2004-12-22 UPLOAD CMT LTR - ITEM 401 8K - 122204 - KRW 0000000000-04-041242 5121
2004-12-16 8-K CURRENT REPORT 4.01 0001169232-04-006081 000-26575 041207872 34 6128
2004-11-30 10-Q/A FORM 10-Q/A 0001169232-04-005936 000-26575 041173157 34 37829
2004-11-24 10-Q/A AMENDMENT TO FORM 10-Q 0001169232-04-005907 000-26575 041166822 34 145514
2004-11-23 10-Q QUARTERLY REPORT 0001169232-04-005865 000-26575 041161950 34 144890
2004-11-15 NT 10-Q FORM 12B-25 0001169232-04-005720 000-26575 041141832 34 9977
2004-08-12 10-Q QUARTERLY REPORT 0001169232-04-004045 000-26575 04968588 37265
2004-05-13 10-Q d59600_10q.txt 0001169232-04-002850 000-26575 04801799 33349
2004-03-30 10-K ANNUAL REPORT 0001169232-04-001981 000-26575 04698248 116353
2003-11-13 10-Q QUARTERLY REPORT 0001169232-03-006588 000-26575 03996423 39088
2003-08-08 10-Q QUARTERLY REPORT 0001169232-03-004992 000-26575 03830638 35888
2003-05-13 10-Q QUARTERLY REPORT 0001169232-03-003597 000-26575 03694263 33268
2003-03-28 10-K ANNUAL REPORT 0001169232-03-002403 000-26575 03624401 107044
2002-11-13 10-Q FORM 10-Q 0001169232-02-002734 000-26575 02818681 40798
2002-08-19 10-Q QUARTERLY REPORT 0001169232-02-001124 000-26575 02742362 24505
2002-08-14 NT 10-Q FORM NT 10-Q 0001169232-02-000970 000-26575 02735609 8615
2002-05-15 10-Q QUARTERLY REPORT 0001005477-02-002189 000-26575 02650509 19996
2002-03-27 10-K FORM 10-K 0001005477-02-001375 000-26575 02588025 95761
2002-02-14 5 US NEUROSURGICAL, INC. 0000932799-02-000043 000-26575 02547597 13008
2002-02-14 SC 13G/A neurosur13g.txt 0000932799-02-000037 005-56875 02546606 10017
2001-11-13 10-Q FORM 10-Q 0001005477-01-501897 000-26575 1783112 25103
2001-08-09 10-Q d01-34103.txt 0001005477-01-500416 000-26575 1702338 23817
2001-05-21 10-Q FORM 10-Q 0001005477-01-003444 000-26575 1644349 19618
2001-05-15 NT 10-Q f12b25form10q.txt 0000932799-01-500027 000-26575 1636937 6430
2001-04-12 10-K FORM 10-K 0001005477-01-002715 000-26575 1601141 92172
2001-03-29 NT 10-K NOTIFICATION OF LATE FILING 0000932799-01-000076 000-26575 1584158 6516
2001-02-15 SC 13G/A AMMENDED STATEMENT OF BENFICIAL OWNERSHIP 0000932799-01-000058 005-56875 1546772 28309
2000-11-14 10-Q FORM 10-Q 0001005477-00-007866 000-26575 764914 28220
2000-08-10 10-Q FORM 10-Q 0001005477-00-005610 000-26575 690493 26695
2000-05-12 10-Q FORM 10-Q 0001005477-00-003880 000-26575 627947 21132
2000-03-30 10-K FORM 10-K 0001005477-00-002653 000-26575 585103 95695
2000-02-14 SC 13G/A 0000932799-00-000023 0000932799-00-000023 005-56875 543527 12041
1999-11-12 10-Q FORM 10-Q 0001005477-99-005158 000-26575 99748257 34044
1999-09-22 SC 13G 0000932799-99-000083 0000932799-99-000083 005-56875 99714929 11927
1999-08-25 10-12G/A U S NEUROSURGICAL INC. FORM 10, AMENDMENT NO. 2 0000950133-99-002929 000-26575 99699099 219287
1999-08-10 10-12G/A U S NEUROSURGICAL INC FORM 10 AMENDMENT NO 1 0000950133-99-002639 000-26575 99682448 218681
1999-07-01 10-12G U S NEUROSURGICAL INC FORM 10 0000950133-99-002348 000-26575 99658110 416917

Latest XBRL company facts

One latest value per concept from companyfacts (351 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 28.68M 2026-11-14 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
dei EntityPublicFloat Entity Public Float USD 23.91M 2025-06-30 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap AccountsNotesAndLoansReceivableNetCurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Current USD 333,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 330,000 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap AccountsReceivableRelatedPartiesNoncurrent Accounts Receivable, Related Parties, Noncurrent USD 140,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001140361-23-024507
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 166,000 2023-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 17.48M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 30,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 122,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AdvertisingExpense Advertising Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 30,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2011-12-31 2011 FY 10-K 2012-03-30 0001140361-12-018385
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 36,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 229,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 32,000 2011-12-31 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 3.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap AssetRetirementObligation Asset Retirement Obligation USD 0 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap AssetRetirementObligationAccretionExpense Asset Retirement Obligation, Accretion Expense USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap AssetRetirementObligationCurrent Asset Retirement Obligation, Current USD 0 2013-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap AssetRetirementObligationLiabilitiesIncurred Asset Retirement Obligation, Liabilities Incurred USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap AssetRetirementObligationLiabilitiesSettled Asset Retirement Obligation, Liabilities Settled USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap AssetRetirementObligationPeriodIncreaseDecrease Asset Retirement Obligation, Period Increase (Decrease) USD 425,000 2011-10-01 2011-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap AssetRetirementObligationsNoncurrent Asset Retirement Obligations, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap Assets Assets USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AssetsCurrent Assets, Current USD 1.46M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 4.25M 2018-09-30 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001140361-18-036346
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 961,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 900,000 2016-04-30 2017 Q3 10-Q 2017-11-17 0001140361-17-043211
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 1.40M 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 85,000 2019-01-01 2019-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 988,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 2.46M 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 960,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 938,000 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 938,000 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 540,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 960,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 391,000 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 50,000 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 2.25M 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesIncomeStatementInterestExpense Capital Leases, Income Statement, Interest Expense USD 18,000 2014-09-01 2016 Q2 10-Q 2016-08-12 0001140361-16-076172
us-gaap CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent Capital Leases, Lessor Balance Sheet, Net Investment in Direct Financing and Sales Type Leases, Current USD 828,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent Capital Leases, Lessor Balance Sheet, Net Investment in Direct Financing and Sales Type Leases, Noncurrent USD 1.42M 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 740,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.17M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.75M 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 740,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 28.68M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 28.68M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 238,000 2024-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap CommonStockValue Common Stock, Value, Issued USD 287,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ConstructionAndDevelopmentCosts Construction and Development Costs (Deprecated 2018-01-31) USD 251,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap ContractualObligation Contractual Obligation USD 4.70M 2016-06-30 2016 Q2 10-Q 2016-08-12 0001140361-16-076172
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 78,000 2014-09-01 2016 Q2 10-Q 2016-08-12 0001140361-16-076172
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 158,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CostMethodInvestments Cost Method Investments USD 355,000 2017-09-30 2017 Q3 10-Q 2017-11-17 0001140361-17-043211
us-gaap CostMethodInvestmentsOriginalCost Cost Method Investments, Original Cost USD 337,000 2016-09-30 2016 Q3 10-Q 2016-11-14 0001140361-16-086382
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 26,000 2017-08-01 2017-08-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap CostOfRevenue Cost of Revenue USD 3.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CostsAndExpenses Costs and Expenses USD 4.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD -260,000 2013-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 18,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD -663,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 314,000 2018-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 881,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001140361-18-023881
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 230,000 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 0 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 0 2016-12-31 2016 FY 10-K 2017-03-31 0001140361-17-014197
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2021-12-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 93,000 2016-06-30 2016 Q2 10-Q 2016-08-12 0001140361-16-076172
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.01M 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 19,000 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Asset Retirement Obligations USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.34M 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 314,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 0 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 179,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001140361-19-020592
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 0 2021-12-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap DepositAssets Deposit Assets USD 248,000 2016-06-30 2016 Q2 10-Q 2016-08-12 0001140361-16-076172
us-gaap Depreciation Depreciation USD 754,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 141,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap DisposalGroupDeferredGainOnDisposal Disposal Group, Deferred Gain on Disposal USD 930,000 2012-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssets Disposal Group, Including Discontinued Operation, Capital Leased Assets USD 898,000 2018-09-30 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredRevenue Disposal Group, Including Discontinued Operation, Deferred Revenue USD 600,000 2018-09-30 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 3.35M 2018-09-30 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DueFromRelatedParties Due from Related Parties USD 70,000 2012-03-31 2012 Q1 10-Q 2012-05-15 0001140361-12-025558
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 0 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap DueFromRelatedPartiesNoncurrent Due from Related Parties, Noncurrent USD 566,000 2019-03-31 2019 Q1 10-Q 2019-05-14 0001140361-19-009121
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 47,000 2022-06-30 2022 Q2 10-Q 2022-08-12 0001140361-22-029417
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.07 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.03 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.208 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.064 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.079 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.067 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 166,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap EquityMethodInvestmentDividendsOrDistributions Proceeds from Equity Method Investment, Distribution USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034794
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.2 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap EquityMethodInvestmentSummarizedFinancialInformationRevenue Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) USD 3.34M 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 89,000 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2021-09-30 2021 Q3 10-Q 2021-11-19 0001140361-21-038700
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 90,000 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 90,000 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2019-09-30 2019 Q3 10-Q 2019-11-14 0001140361-19-020592
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 0 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 0 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 90,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001140361-20-025513
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.059 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent USD 523,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap GainLossOnSaleOfEquityInvestments Gain (Loss) on Sale of Equity Investments USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap GainOnBusinessInterruptionInsuranceRecovery Gain on Business Interruption Insurance Recovery USD 3.27M 2012-01-01 2012-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap Goodwill Goodwill USD 984,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap GrossProfit Gross Profit USD 414,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap HealthCareOrganizationExpensesNet Health Care Organization, Expenses, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap HealthCareOrganizationPatientServiceRevenue Health Care Organization, Patient Service Revenue (Deprecated 2018-01-31) USD 865,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001140361-18-023881
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 176,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -7.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 729,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0.09 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001437749-26-028491
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 2,000 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -362,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 101,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001140361-19-020592
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 184,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 504,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 13,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 163,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -529,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 552,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001140361-18-043097
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap IncreaseDecreaseInAssetRetirementObligations Increase (Decrease) in Asset Retirement Obligations USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001140361-14-041417
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -164,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001437749-26-028491
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 0 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-12 0001140361-22-029417
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 511,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001140361-18-023881
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001437749-25-017141
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap IncreaseDecreaseInDueToAffiliatesCurrent Increase (Decrease) in Due to Affiliates, Current USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034794
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable USD 321,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-19 0001140361-21-038700
us-gaap IncreaseDecreaseInInsuranceLiabilities Increase (Decrease) in Insurance Liabilities USD 80,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap InsuranceRecoveries Insurance Recoveries USD 930,000 2012-10-31 2017 Q3 10-Q 2017-11-17 0001140361-17-043211
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 0 2013-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 51,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap InterestExpense Interest Expense USD 1,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 13,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001437749-26-028491
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 40,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001140361-17-020222
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap InterestReceivable Interest Receivable USD 15,000 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 15,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001140361-19-020592
us-gaap LeaseCost Lease, Cost USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 0 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap LeaseIncome Lease Income USD 7,000 2020-01-01 2020-12-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.041 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 24,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001140361-19-020592
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 24,000 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 31,000 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025847
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 39,000 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 9,000 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034794
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap Liabilities Liabilities USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 45,000 2021-09-30 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 1.14M 2018-09-30 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap LongTermAccountsNotesAndLoansReceivableNetNoncurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0001437749-25-017141
us-gaap LongTermDebt Long-term Debt USD 4.10M 2017-12-31 2018 Q3 10-Q 2018-11-14 0001140361-18-043097
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 2.75M 2016-03-31 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 774,000 2016-03-31 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 755,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap MaintenanceCosts Maintenance Costs (Deprecated 2018-01-31) USD 26,000 2017-08-01 2017-08-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap MaintenanceRevenue Maintenance Revenue (Deprecated 2018-01-31) USD 264,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap MalpracticeInsuranceAnnualCoverageLimit Malpractice Insurance, Annual Coverage Limit USD 3.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap MalpracticeInsuranceDeductible Malpractice Insurance, Deductible (Deprecated 2013-01-31) USD 525,000 2012-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -250,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001140361-17-020222
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -58,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001140361-17-020222
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 1.79M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001140361-17-020222
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -4.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034794
us-gaap NetInvestmentInLeaseCurrent Net Investment in Lease, Current USD 0 2021-12-31 2021 FY 10-K/A 2022-06-24 0001140361-22-023989
us-gaap NetInvestmentInLeaseNoncurrent Net Investment in Lease, Noncurrent USD 0 2021-09-30 2021 Q3 10-Q 2021-11-19 0001140361-21-038700
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 315,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -215,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 575,000 2018-09-30 2018 Q3 10-Q 2018-11-14 0001140361-18-043097
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-04-07 0001140361-21-011976
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 525,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034956
us-gaap NotesReceivableRelatedPartiesNoncurrent Notes Receivable, Related Parties, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap OperatingExpenses Operating Expenses USD 476,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseCost Operating Lease, Cost USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 38,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 34,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 200,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 42,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 24,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 46,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 45,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 43,000 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 24,000 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap OperatingLeasesIncomeStatementMinimumLeaseRevenue Operating Leases, Income Statement, Minimum Lease Revenue USD 30,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-11 0001140361-18-018180
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 42,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.041 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025847
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 915,000 2016-12-31 2016 FY 10-K 2017-03-31 0001140361-17-014197
us-gaap OriginationOfNotesReceivableFromRelatedParties Origination of Notes Receivable from Related Parties USD 11,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap OtherAssetsCurrent Other Assets, Current USD 284,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0001437749-25-017141
us-gaap OtherCommitment Other Commitment USD 4.70M 2016-03-31 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear Other Commitment, to be Paid, Remainder of Fiscal Year USD 78,000 2014-09-01 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap OtherIncome Other Income USD 26,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001140361-15-032164
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 13,000 2016-03-31 2016 Q1 10-Q 2016-05-12 0001140361-16-064750
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 9,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-19 0001140361-21-038700
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -51,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001140361-17-014197
us-gaap PaymentsForProceedsFromBusinessesAndInterestInAffiliates Payments for (Proceeds from) Businesses and Interest in Affiliates USD -57,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap PaymentsForRemovalCosts Payments for Removal Costs USD 525,000 2012-10-31 2017 Q3 10-Q 2017-11-17 0001140361-17-043211
us-gaap PaymentsOfDistributionsToAffiliates Payments of Distributions to Affiliates USD 4,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001140361-18-043097
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap PaymentsToAcquireBusinessesAndInterestInAffiliates Payments to Acquire Businesses and Interest in Affiliates USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034956
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-13 0001140361-20-008735
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ProceedsFromCollectionOfAdvanceToAffiliate Proceeds from Collection of Advance to Affiliate USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-11 0001140361-19-006932
us-gaap ProceedsFromCollectionOfLeaseReceivables Proceeds from Collection of Lease Receivables USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates Proceeds from Divestiture of Interest in Subsidiaries and Affiliates USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-04-14 0001140361-14-016669
us-gaap ProceedsFromInsuranceSettlementInvestingActivities Proceeds from Insurance Settlement, Investing Activities USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 275,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 14.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap ProceedsFromLeasePayments Proceeds from Lease Payment, Operating Activity USD 202,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001140361-19-009121
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 755,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap ProceedsFromRepaymentsOfRestrictedCashFinancingActivities Proceeds from (Repayments of) Restricted Cash, Financing Activities USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001140361-12-046592
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 250,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.83M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001437749-26-028491
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 3.74M 2009-01-01 2009-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure USD 2.57M 2017-09-30 2017 Q3 10-Q 2017-11-17 0001140361-17-043211
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001140361-16-059518
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-30 0001140361-12-018385
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -16.56M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001140361-15-013673
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 85,000 2019-01-01 2019-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap SalesTypeLeaseInterestIncome Sales-type Lease, Interest Income USD 0 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001140361-23-053308
us-gaap SalesTypeLeaseLeaseReceivable Sales-type Lease, Lease Receivable USD 2.45M 2018-09-30 2022 FY 10-K 2023-04-13 0001140361-23-018265
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 4.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 112,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.393 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 4.50M 2025-10-31 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 198,349 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.95 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 0.86 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 398,000 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.95 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 50,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap SharesOutstanding Shares, Outstanding shares 4.23M 2025-03-31 2025 Q3 10-Q 2025-11-13 0001437749-25-034794
us-gaap ShortTermBorrowings Short-term Debt USD 200,000 2014-09-30 2014 Q3 10-Q 2014-11-13 0001140361-14-041417
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 4.18M 2024-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap StockIssued1 Stock Issued USD 742,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 5,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-02 0001437749-25-010652
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 153,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-04-01 0001140361-13-014649
us-gaap SubleaseIncome Sublease Income USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap UnusualOrInfrequentItemLossGross Unusual or Infrequent Item, or Both, Loss, Gross USD 233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001437749-26-012312
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 11.90M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001140361-24-026235
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 7.79M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-19 0001140361-21-038700
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-05 0001140361-24-018303
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 28.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001437749-26-037860
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 7.80M 2012-03-31 2012 Q1 10-Q 2012-05-15 0001140361-12-025558

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →